128 related articles for article (PubMed ID: 12847477)
1. Impact of intranasal budesonide on immune inflammatory responses and epithelial remodeling in chronic upper airway inflammation.
Mastruzzo C; Greco LR; Nakano K; Nakano A; Palermo F; Pistorio MP; Salinaro ET; Jordana M; Dolovich J; Crimi DN; Vancheri C
J Allergy Clin Immunol; 2003 Jul; 112(1):37-44. PubMed ID: 12847477
[TBL] [Abstract][Full Text] [Related]
2. Corticosteroid treatment regulates mucosal remodeling in chronic rhinosinusitis with nasal polyps.
de Borja Callejas F; Martínez-Antón A; Picado C; Alobid I; Pujols L; Valero A; Roca-Ferrer J; Mullol J
Laryngoscope; 2015 May; 125(5):E158-67. PubMed ID: 25641502
[TBL] [Abstract][Full Text] [Related]
3. IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis.
Shin HW; Kim DK; Park MH; Eun KM; Lee M; So D; Kong IG; Mo JH; Yang MS; Jin HR; Park JW; Kim DW
J Allergy Clin Immunol; 2015 Jun; 135(6):1476-85.e7. PubMed ID: 25725991
[TBL] [Abstract][Full Text] [Related]
4. IL-11 and IL-17 expression in nasal polyps: relationship to collagen deposition and suppression by intranasal fluticasone propionate.
Molet SM; Hamid QA; Hamilos DL
Laryngoscope; 2003 Oct; 113(10):1803-12. PubMed ID: 14520110
[TBL] [Abstract][Full Text] [Related]
5. Montelukast reduces eosinophilic inflammation by inhibiting both epithelial cell cytokine secretion (GM-CSF, IL-6, IL-8) and eosinophil survival.
Mullol J; Callejas FB; Méndez-Arancibia E; Fuentes M; Alobid I; Martínez-Antón A; Valero A; Picado C; Roca-Ferrer J
J Biol Regul Homeost Agents; 2010; 24(4):403-11. PubMed ID: 21122279
[TBL] [Abstract][Full Text] [Related]
6. Nasal polyposis: from cytokines to growth.
Bachert C; Gevaert P; Holtappels G; Cuvelier C; van Cauwenberge P
Am J Rhinol; 2000; 14(5):279-90. PubMed ID: 11068652
[TBL] [Abstract][Full Text] [Related]
7. Stem cell factor in nasal polyposis and allergic rhinitis: increased expression by structural cells is suppressed by in vivo topical corticosteroids.
Kim YK; Nakagawa N; Nakano K; Sulakvelidze I; Dolovich J; Denburg J
J Allergy Clin Immunol; 1997 Sep; 100(3):389-99. PubMed ID: 9314353
[TBL] [Abstract][Full Text] [Related]
8. Corticosteroid therapy increases membrane-tethered while decreases secreted mucin expression in nasal polyps.
Martínez-Antón A; de Bolós C; Alobid I; Benítez P; Roca-Ferrer J; Picado C; Mullol J
Allergy; 2008 Oct; 63(10):1368-76. PubMed ID: 18547287
[TBL] [Abstract][Full Text] [Related]
9. [Effects of intranasal budesonide on the infiltration and activation of eosinophils in nasal polyps].
Zhang L; Han D; Zhang Y; Zhou B
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2000 Apr; 35(2):129-32. PubMed ID: 12768671
[TBL] [Abstract][Full Text] [Related]
10. Evaluating budesonide efficacy in nasal polyposis and predicting the resistance to treatment.
Valera FC; Queiroz R; Scrideli C; Tone LG; Anselmo-Lima WT
Clin Exp Allergy; 2009 Jan; 39(1):81-8. PubMed ID: 19068102
[TBL] [Abstract][Full Text] [Related]
11. Airway inflammation in nasal polyposis: immunopathological aspects of relation to asthma.
Ediger D; Sin BA; Heper A; Anadolu Y; Misirligil Z
Clin Exp Allergy; 2005 Mar; 35(3):319-26. PubMed ID: 15784110
[TBL] [Abstract][Full Text] [Related]
12. Effect of intranasal fluticasone on cellular infiltration, endothelial adhesion molecule expression, and proinflammatory cytokine mRNA in nasal polyp disease.
Hamilos DL; Thawley SE; Kramper MA; Kamil A; Hamid QA
J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):79-87. PubMed ID: 9893189
[TBL] [Abstract][Full Text] [Related]
13. Eosinophil activation in the tissue: synthetic steroid, budesonide, effectively inhibits the survival of eosinophils isolated from peripheral blood but not nasal polyp tissues.
Nonaka R; Nonaka M; Takanashi S; Jordana M; Dolovich J
J Clin Lab Immunol; 1999; 51(1):39-53. PubMed ID: 11424740
[TBL] [Abstract][Full Text] [Related]
14. The pathogenesis of nasal polyposis by immunoglobulin E and interleukin-5 is completed by transforming growth factor-beta1.
Hirschberg A; Jókúti A; Darvas Z; Almay K; Répássy G; Falus A
Laryngoscope; 2003 Jan; 113(1):120-4. PubMed ID: 12514394
[TBL] [Abstract][Full Text] [Related]
15. Effect of desloratadine on epithelial cell granulocyte-macrophage colony-stimulating factor secretion and eosinophil survival.
Mullol J; Roca-Ferrer J; Alobid I; Pujols L; Valero A; Xaubet A; Bernal-Sprekelsen M; Picado C
Clin Exp Allergy; 2006 Jan; 36(1):52-8. PubMed ID: 16393266
[TBL] [Abstract][Full Text] [Related]
16. Profibrotic transforming growth factor beta 1 and activin A are increased in nasal polyp tissue and induced in nasal polyp epithelium by cigarette smoke and Toll-like receptor 3 ligation.
Yamin M; Holbrook EH; Gray ST; Busaba NY; Lovett B; Hamilos DL
Int Forum Allergy Rhinol; 2015 Jul; 5(7):573-82. PubMed ID: 25914020
[TBL] [Abstract][Full Text] [Related]
17. Nasal polyp inflammation. Effect of topical nasal steroid.
Kanai N; Denburg J; Jordana M; Dolovich J
Am J Respir Crit Care Med; 1994 Oct; 150(4):1094-100. PubMed ID: 7921442
[TBL] [Abstract][Full Text] [Related]
18. Effect of budesonide and nedocromil sodium on IL-6 and IL-8 release from human nasal mucosa and polyp epithelial cells.
Xaubet A; Mullol J; Roca-Ferrer J; Pujols L; Fuentes M; Pérez M; Fabra JM; Picado C
Respir Med; 2001 May; 95(5):408-14. PubMed ID: 11392584
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Budesonide Nasal Spray on Neutrophilic Chronic Rhinosinusitis with Nasal Polyps: A Combined Clinical and Experimental Study.
Lin L; Lan J; Dai F; Wei J; Chen Z; Sun G
Int Arch Allergy Immunol; 2020; 181(7):551-562. PubMed ID: 32369807
[TBL] [Abstract][Full Text] [Related]
20. Correlation between cytokine levels in nasal fluid and eosinophil counts in nasal polyp tissue in asthmatic and non-asthmatic patients.
Perić A; Vojvodić D; Radulović V; Vukomanović-Đurđević B; Miljanović O
Allergol Immunopathol (Madr); 2011; 39(3):133-9. PubMed ID: 21211895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
